Manipal Health Enterprises IPO Day 2 Live: Total sub at 0.45x - Check analysts view and more

0 min read     Updated on 30 Jul 2026, 05:23 PM
scanx
Reviewed by
Ritika DScanX News Team
AI Summary

Manipal Health Enterprises IPO is subscribed 0.45x on Day 2. QIBs show highest interest at 0.6x, followed by Employees at 1.45x. The price band is ₹560-₹590 with a min bid qty of 25.

powered bylight_fuzz_icon
46957976

*this image is generated using AI for illustrative purposes only.

Manipal Health Enterprises IPO is currently in its second day of subscription, with the issue subscribed 0.45x so far. Qualified Institutional Buyers (QIB) lead the interest with a 0.6x subscription, while Retail investors have subscribed 0.45x.

Subscription Status

The IPO saw mixed interest across categories on Day 2. Here is the breakdown of the subscription status:

Category Subscription Multiple
Qualified Institutional Buyers (QIB) 0.6 x
Employees 1.45 x
Retail 0.45 x
Non-Institutional Buyers (bHNI) 0.14 x
Non-Institutional Buyers (sHNI) 0.15 x
Total Subscribed 0.45 x

About the Company

Manipal Health Enterprises is offering shares to the public with a price band between ₹560 and ₹590. The company has set a minimum bid quantity of 25 shares for investors.

Key Dates

Investors looking to apply should note the following offer details:

  • Floor Price: ₹560.00000
  • Ceiling Price: ₹590.00000
  • Min IPO Size: 14000
  • Max IPO Size: 500000
  • Min Bid Qty: 25

Will the strong 1.45x subscription from employees help stabilize the overall demand if retail and QIB interest remains subdued on the final day?

How might the low Non-Institutional Buyer (NIB) participation impact the post-listing liquidity and price volatility of Manipal Health Enterprises?

Given the current 0.45x total subscription, is there a risk of the IPO being undersubscribed, and what measures could the book-runners take to boost interest?

like18
dislike

Manipal Health Enterprises IPO Day 1: Subscription status, review — here's what you need to know

0 min read     Updated on 29 Jul 2026, 05:23 PM
scanx
Reviewed by
Ritika DScanX News Team
AI Summary

Manipal Health Enterprises IPO is open for subscription with a price band of ₹560-₹590. Day 1 data shows total subscription at 0.12x. QIBs are at 0.12x, Employees at 0.74x, and Retail at 0.19x. The minimum bid quantity is 25 shares.

powered bylight_fuzz_icon
46871620

*this image is generated using AI for illustrative purposes only.

Manipal Health Enterprises IPO opened for subscription today. On the first day of bidding, the issue has been subscribed 0.12 times so far. Retail investors showed the highest interest among categories at 0.19x, while Qualified Institutional Buyers (QIB) subscribed 0.12x.

Subscription Status

The following table details the Day 1 subscription numbers across different investor categories:

Category Subscription Multiple
Qualified Institutional Buyers (QIB) 0.12 x
Non-Institutional Buyers (bHNI) 0.06 x
Non-Institutional Buyers (sHNI) 0.06 x
Employees 0.74 x
Retail 0.19 x
Total Subscribed 0.12 x

About the Company

Manipal Health Enterprises is a key player in the healthcare sector. The company’s IPO aims to raise capital through a fresh issue and/or offer for sale. Investors are closely watching the subscription trends as the bidding window remains open.

Offer Details

Here are the key details of the Manipal Health Enterprises IPO:

  • Price Band: ₹560 - ₹590
  • Issue Size: ₹14,000 - ₹5,00,000
  • Minimum Bid Quantity: 25 shares
  • IPO Stage: Day 1 Open

How might the weak Day 1 subscription impact the final listing price and potential premium or discount at listing?

What strategies could the book-running lead managers employ to attract more QIB and NII interest in the remaining bidding days?

Will the healthcare sector's current valuation trends influence investor sentiment towards Manipal Health Enterprises as the IPO window closes?

like15
dislike

Manipal Health Enterprises IPO

IPO Open Now
Price Range ₹ 560 – ₹ 590
Min Investment₹ 14,000
Issue Size₹ 9,275.22 Cr.
Lot Size25
Date29 Jul - 31 Jul
View IPO Details arrow